Analyst Price Targets — NEOG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 12, 2026 12:05 pm | David Westenberg | Piper Sandler | $10.00 | $9.27 | TheFly | Neogen price target raised to $10 from $6.50 at Piper Sandler |
| January 9, 2026 11:55 am | — | Guggenheim | $12.00 | $9.71 | TheFly | Neogen price target raised to $12 from $8 at Guggenheim |
| October 16, 2025 10:49 am | David Westenberg | Piper Sandler | $6.50 | $5.95 | TheFly | Neogen price target raised to $6.50 from $5 at Piper Sandler |
| April 22, 2025 11:06 am | David Westenberg | Piper Sandler | $5.00 | $4.75 | TheFly | Neogen price target lowered to $5 from $6.40 at Piper Sandler |
| August 6, 2024 7:21 am | David Westenberg | Piper Sandler | $17.50 | $16.15 | TheFly | Neogen price target raised to $17.50 from $17 at Piper Sandler |
| December 14, 2022 6:34 pm | David Westenberg | Piper Sandler | $17.00 | $15.35 | TheFly | Neogen price target raised to $17 from $14 at Piper Sandler |
| October 9, 2022 8:57 pm | David Westenberg | Piper Sandler | $14.00 | $12.68 | TheFly | Neogen price target lowered to $14 from $20 at Piper Sandler |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for NEOG

Neogen (NASDAQ: NEOG - Get Free Report) and Sunny Optical Technology (Group) (OTCMKTS:SNPTF - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Profitability This table compares Neogen and Sunny

CIBC Bancorp USA Inc. purchased a new stake in Neogen Corporation (NASDAQ: NEOG) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 5,073,316 shares of the company's stock, valued at approximately $28,969,000. CIBC Bancorp USA Inc. owned approximately 2.33% of Neogen at the

Clarkston Capital Partners LLC cut its stake in Neogen Corporation (NASDAQ: NEOG) by 16.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,693,250 shares of the company's stock after selling 2,312,475 shares during the quarter. Neogen makes up approximately

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc. (“Zoetis”), the world's leading animal health company, for $160 million, subject to customary closing adjustments. The planned divestiture, which had been previously announced, was part of the…

Shares of Neogen Corporation (NASDAQ: NEOG - Get Free Report) have been given a consensus recommendation of "Hold" by the six research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NEOG.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
